Wei‐Chen Tai

2.2k total citations
120 papers, 1.6k citations indexed

About

Wei‐Chen Tai is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Chen Tai has authored 120 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 53 papers in Gastroenterology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Chen Tai's work include Gastroesophageal reflux and treatments (37 papers), Helicobacter pylori-related gastroenterology studies (37 papers) and Liver Disease Diagnosis and Treatment (21 papers). Wei‐Chen Tai is often cited by papers focused on Gastroesophageal reflux and treatments (37 papers), Helicobacter pylori-related gastroenterology studies (37 papers) and Liver Disease Diagnosis and Treatment (21 papers). Wei‐Chen Tai collaborates with scholars based in Taiwan, United States and Australia. Wei‐Chen Tai's co-authors include Seng‐Kee Chuah, Keng‐Liang Wu, Chih‐Ming Liang, Yi‐Chun Chiu, Tsung‐Hui Hu, Ming‐Luen Hu, Chen‐Hsiang Lee, Chung‐Mou Kuo, Cheng‐Kun Wu and Yuan‐Hung Kuo and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Wei‐Chen Tai

114 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei‐Chen Tai Taiwan	24	958	486	377	349	299	120	1.6k
Zahid A. Saeed United States	14	1.6k 1.7×	732 1.5×	473 1.3×	471 1.3×	436 1.5×	31	2.1k
King‐Wah Chiu Taiwan	26	1.2k 1.2×	264 0.5×	802 2.1×	420 1.2×	966 3.2×	155	2.5k
Babu Ram Thapa India	25	956 1.0×	334 0.7×	538 1.4×	350 1.0×	412 1.4×	119	1.7k
P. Pazzi Italy	22	870 0.9×	182 0.4×	259 0.7×	562 1.6×	247 0.8×	82	1.5k
Davide Roccarina Italy	23	787 0.8×	240 0.5×	685 1.8×	171 0.5×	652 2.2×	70	1.7k
Francisco Bosques‐Padilla Mexico	22	651 0.7×	172 0.4×	636 1.7×	191 0.5×	224 0.7×	115	1.7k
Felipe Bory Spain	23	1.1k 1.2×	389 0.8×	1.0k 2.7×	426 1.2×	1.2k 3.9×	43	2.1k
Surender Kumar Yachha India	26	1.4k 1.5×	445 0.9×	961 2.5×	285 0.8×	920 3.1×	180	2.3k
Dae Young Cheung South Korea	22	889 0.9×	578 1.2×	179 0.5×	551 1.6×	32 0.1×	111	1.5k
Naoyoshi Nagata Japan	30	1.8k 1.9×	1.1k 2.3×	339 0.9×	567 1.6×	63 0.2×	146	2.8k

Countries citing papers authored by Wei‐Chen Tai

Since Specialization

Citations

This map shows the geographic impact of Wei‐Chen Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chen Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chen Tai more than expected).

Fields of papers citing papers by Wei‐Chen Tai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chen Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chen Tai. The network helps show where Wei‐Chen Tai may publish in the future.

Co-authorship network of co-authors of Wei‐Chen Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chen Tai. A scholar is included among the top collaborators of Wei‐Chen Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chen Tai. Wei‐Chen Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Dang, Seng‐Kee Chuah, John Y. Kao, et al.. (2025). Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus. Journal of the Formosan Medical Association.

Hsu, Ping‐I, Chien‐Lin Chen, Kuan-Yang Chen, et al.. (2025). Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial. The American Journal of Gastroenterology. 2 indexed citations

Tai, Wei‐Chen, Pao‐Yuan Huang, Chih‐Chien Yao, et al.. (2024). The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan. Journal of Microbiology Immunology and Infection. 57(4). 601–608. 2 indexed citations

Huang, Pao‐Yuan, Shih‐Cheng Yang, Ming‐Kung Wu, et al.. (2023). Correlation between Psychosomatic Assessment, Heart Rate Variability, and Refractory GERD: A Prospective Study in Patients with Acid Reflux Esophagitis. Life. 13(9). 1862–1862. 5 indexed citations

Hsu, Ping‐I, Kuan-Yang Chen, Wei‐Chen Tai, et al.. (2023). Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. The American Journal of Gastroenterology. 118(7). 1184–1195. 12 indexed citations

Tai, Wei‐Chen, Shih‐Cheng Yang, Lung‐Sheng Lu, et al.. (2023). The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up. Infection and Drug Resistance. Volume 16. 6167–6174. 2 indexed citations

Chou, Yeh‐Pin, Wei‐Chen Tai, Lung‐Sheng Lu, et al.. (2021). Endoscopic submucosal dissection and radiofrequency ablation for patients with flat‐type esophageal squamous cell neoplasia. Advances in digestive medicine. 9(3). 153–160. 1 indexed citations

Wu, Cheng‐Kun, Chien‐Ning Hsu, Shih‐Cheng Yang, et al.. (2021). Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis. Infection and Drug Resistance. Volume 14. 2121–2131. 4 indexed citations

Yao, Chih‐Chien, Chung‐Mou Kuo, Chien‐Ning Hsu, et al.. (2019). First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infection and Drug Resistance. Volume 12. 1425–1431. 17 indexed citations

10.

Liang, Chih‐Ming, Shih‐Cheng Yang, Cheng‐Kun Wu, et al.. (2019). Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs. Journal of Clinical Medicine. 8(10). 1722–1722. 8 indexed citations

11.

Tai, Wei‐Chen, Chih‐Ming Liang, Chung‐Mou Kuo, et al.. (2019). A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial. Infection and Drug Resistance. Volume 12. 2923–2931. 7 indexed citations

12.

Wu, Cheng‐Kun, Shih‐Cheng Yang, Yuchi Li, et al.. (2019). The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. Journal of Gastroenterology and Hepatology. 35(5). 777–787. 8 indexed citations

13.

Wu, Deng‐Chyang, Pin‐I Hsu, Chao‐Hung Kuo, et al.. (2019). Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial. Drug Design Development and Therapy. Volume 13. 1347–1356. 5 indexed citations

14.

Wu, Cheng‐Kun, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health. 15(12). 2655–2655. 13 indexed citations

15.

Huang, Pao‐Yuan, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms. The Kaohsiung Journal of Medical Sciences. 34(11). 650–656. 16 indexed citations

16.

Wu, Cheng‐Kun, Hon‐Yi Shi, Wei‐Chen Tai, et al.. (2016). Medical expenses in treating acute esophageal variceal bleeding. Medicine. 95(28). e4215–e4215. 10 indexed citations

17.

Lee, Chen‐Hsiang, Yuan‐Hung Kuo, Keng‐Liang Wu, et al.. (2016). First‐line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan. The Kaohsiung Journal of Medical Sciences. 32(8). 397–402. 7 indexed citations

18.

Wang, Jing‐Houng, Seng‐Kee Chuah, Sheng‐Nan Lu, et al.. (2014). Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver International. 34(9). 1340–1348. 36 indexed citations

19.

Kuo, Yuan‐Hung, Seng‐Kee Chuah, Yi‐Chun Chiu, et al.. (2009). Mantle Cell Lymphoma with Diffuse Gastrointestinal Tract Involvement: A Case Report. 20(6). 555–560. 2 indexed citations

20.

Tai, Wei‐Chen, Seng-Kee Chuah, Chao‐Cheng Huang, et al.. (2008). Liver Tuberculosis in Southern Taiwan: 15-years Clinical Experience. 19(5). 410–417. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact